BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Neurotechnology Releases SentiGaze SDK For Eye Movement Tracking Using Ordinary Webcams

  March 2, 2015

   · 

  3 min read
• Drug Development

  Oncolytics Biotech Inc. Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube

  March 2, 2015

   · 

  4 min read
• Drug Development

  Otsuka Pharmaceutical Co., Ltd. Release: First-Ever Treatment Approved In Canada For Adults Living With ADPKD, A Life-Threatening Kidney Disease

  March 2, 2015

   · 

  8 min read
• Policy

  Shire Submits Application To The U.S. D&A Pharma For Approval Of Lifitegrast For Treatment Of Dry Eye Disease In Adults

  March 2, 2015

   · 

  2 min read
• Biotech Beach

  VG Life Sciences, Inc. Granted Key Composition Of Matter Patent

  March 2, 2015

   · 

  3 min read
• Drug Development

  TRACON Pharmaceuticals, Inc. Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium

  March 2, 2015

   · 

  7 min read
• Drug Development

  Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial

  March 2, 2015

   · 

  4 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Announces Full Results From Positive Phase 3 ANNEXA-R Study Demonstrating That Andexanet Alfa Rapidly And Significantly Reversed Anticoagulant Effect Of Factor Xa Inhibitor XARELTO

  March 2, 2015

   · 

  11 min read
• Business

  Athersys, Inc. And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan

  March 2, 2015

   · 

  10 min read
• Business

  Hemispherx Biopharma Announces The Completion Of The Newly Upgraded Alferon Facility: Commercial Production Of Alferon Is In The Final Stage Integrating Continuous Flow Manufacturing Technology

  March 2, 2015

   · 

  6 min read